IBRUTINIB-INDUCED HYPERLEUKOCYTOSIS AND LEUKOSTASIS IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA

被引：1

作者：

Ibrahim, Samer

Seshan, Nandini

Berges, Phillip

Hussain, Najia

Defraia, Charles

Zuhoski, Alexander

Hussain, Kashif

机构：

来源：

CHEST | 2019年 / 156卷 / 04期

关键词：

D O I：

10.1016/j.chest.2019.08.2091

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：2149A / 2150A

页数：2

共 3 条

[1] Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies [J].

Advani, Ranjana H. ;

Buggy, Joseph J. ;

Sharman, Jeff P. ;

Smith, Sonali M. ;

Boyd, Thomas E. ;

Grant, Barbara ;

Kolibaba, Kathryn S. ;

Furman, Richard R. ;

Rodriguez, Sara ;

Chang, Betty Y. ;

Sukbuntherng, Juthamas ;

Izumi, Raquel ;

Hamdy, Ahmed ;

Hedrick, Eric ;

Fowler, Nathan H. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) :88-94

[2] Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein [J].

Cukierman, T ;

Gatt, ME ;

Libster, D ;

Goldschmidt, N ;

Matzner, Y .

LEUKEMIA & LYMPHOMA, 2002, 43 (09) :1865-1868

[3] Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study [J].

Herman, S. E. M. ;

Niemann, C. U. ;

Farooqui, M. ;

Jones, J. ;

Mustafa, R. Z. ;

Lipsky, A. ;

Saba, N. ;

Martyr, S. ;

Soto, S. ;

Valdez, J. ;

Gyamfi, J. A. ;

Maric, I. ;

Calvo, K. R. ;

Pedersen, L. B. ;

Geisler, C. H. ;

Liu, D. ;

Marti, G. E. ;

Aue, G. ;

Wiestner, A. .

LEUKEMIA, 2014, 28 (11) :2188-2196

← 1 →